GEODE CAPITAL MANAGEMENT, LLC

Position in PVLA — Palvella Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in PVLA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$42,203,382

+$16,574,221 QoQ

Shares Held

276,164

+34.3% QoQ

Ownership

1.92%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 197 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. PVLA ranks #94 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$42,203,382	276,164	+34.3%	Shares	Defined	2026-08-12
2026-03-31	$25,629,161	205,609	+14.9%	Shares	Defined	2026-05-15
2025-12-31	$18,735,092	178,992	+6.5%	Shares	Defined	2026-02-09
2025-09-30	$10,538,815	168,110	-3.4%	Shares	Defined	2025-11-12
2025-06-30	$3,921,644	173,986	+84.7%	Shares	Defined	2025-08-08
2025-03-31	$2,636,629	94,199	+560.1%	Shares	Defined	2025-05-13
2024-12-31	$171,240	14,270	—	Shares	Defined	2025-02-12
2024-09-30 PIRS	—	11,981	+12.8%	Shares	Defined	2024-11-12
2024-06-30 PIRS	—	10,623	—	Shares	Defined	2024-08-09
No filing history on record for this holder in this stock.